RFG Advisory LLC Acquires 1,620 Shares of Intuitive Surgical, Inc. $ISRG

Posted by Brian Himes on Jun 27th, 2026

RFG Advisory LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 45.6% during the 1st quarter, HoldingsChannel reports. The firm owned 5,170 shares of the medical equipment provider’s stock after purchasing an additional 1,620 shares during the period. RFG Advisory LLC’s holdings in Intuitive Surgical were worth $2,383,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of ISRG. Fifth Third Wealth Advisors LLC lifted its stake in Intuitive Surgical by 28.5% in the first quarter. Fifth Third Wealth Advisors LLC now owns 15,672 shares of the medical equipment provider’s stock valued at $7,225,000 after buying an additional 3,476 shares in the last quarter. Brown Lisle Cummings Inc. increased its position in shares of Intuitive Surgical by 4.7% during the first quarter. Brown Lisle Cummings Inc. now owns 2,863 shares of the medical equipment provider’s stock worth $1,320,000 after acquiring an additional 129 shares in the last quarter. OP Asset Management Ltd acquired a new stake in shares of Intuitive Surgical during the first quarter worth $16,722,000. Banque Cantonale Vaudoise raised its holdings in shares of Intuitive Surgical by 29.9% during the first quarter. Banque Cantonale Vaudoise now owns 14,732 shares of the medical equipment provider’s stock worth $6,792,000 after acquiring an additional 3,387 shares during the period. Finally, Apella Capital LLC bought a new stake in Intuitive Surgical in the 1st quarter valued at $416,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.3%

Shares of ISRG stock opened at $404.70 on Friday. Intuitive Surgical, Inc. has a 1 year low of $396.68 and a 1 year high of $603.88. The firm’s fifty day moving average price is $432.67 and its two-hundred day moving average price is $484.61. The firm has a market capitalization of $143.33 billion, a P/E ratio of 49.05, a PEG ratio of 3.25 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.81 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president directly owned 6,463 shares in the company, valued at $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the transaction, the executive vice president directly owned 5,720 shares in the company, valued at $2,426,080.80. This trade represents a 6.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 7,169 shares of company stock worth $3,059,135. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ISRG. BTIG Research reaffirmed a “buy” rating and issued a $574.00 target price on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. Barclays set a $651.00 price target on Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Evercore reduced their price objective on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research report on Monday, April 6th. Raymond James Financial decreased their price objective on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a report on Wednesday, April 22nd. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $573.42.

View Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.